Beneficial effects of vasodilators in preventing severe acute pancreatitis shock

Pancreas

Volumn 32, Issue 4, 2006, Pages 335-342

  Hernández Barbáchano, Ernesto ^a   San Román, José Ignacio ^a   López, María A ^a   Coveñas, Rafael ^a   López Novoa, José Miguel ^a   Calvo, José Julián ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Cardiocirculatory collapse; CGRP; Mean arterial pressure; Nitric oxide; Rat; VIP

Indexed keywords

AMYLASE; CALCITONIN GENE RELATED PEPTIDE; N ACETYL S NITROSOPENICILLAMINE; N(G) NITROARGININE METHYL ESTER; TAUROCHOLIC ACID; VASOACTIVE INTESTINAL POLYPEPTIDE; VASODILATOR AGENT; DRUG DERIVATIVE; NITRIC OXIDE; PENICILLAMINE; S NITRO N ACETYLPENICILLAMINE; S-NITRO-N-ACETYLPENICILLAMINE;

ACUTE PANCREATITIS; AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HISTOLOGY; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SHOCK; TREATMENT OUTCOME; VASODILATATION; ACUTE DISEASE; ANIMAL; BLOOD; BLOOD PRESSURE; DRUG EFFECT; MALE; PANCREATITIS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; WISTAR RAT;

ACUTE DISEASE; AMYLASES; ANIMALS; BLOOD PRESSURE; CALCITONIN GENE-RELATED PEPTIDE; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PANCREATITIS; PENICILLAMINE; RATS; RATS, WISTAR; SHOCK; VASOACTIVE INTESTINAL PEPTIDE; VASODILATOR AGENTS;

EID: 33646832357     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpa.0000220856.47754.c4     Document Type: Article

References (36)

1. Nagar AB, Gorelick FS. Acute pancreatitis. Curr Opin Gastroenterol. 2002;18:552-557.
2. Weber CK, Adler G. Acute pancreatitis. Curr Opin Gastroenterol. 2003;19:447-450.
3. Menger MD, Plusczyk T, Vollmar B. Microcirculatory derangements in acute pancreatitis. J Hepatobiliary Pancreat Surg. 2001;8:187-194.
4. Klar E, Scharatt W, Foizik T, et al. Impact of microcirculatory flow pattern changes on the development of acute edematous and necrotizing pancreatitis in rabbits. Dig Dis Sci. 1994;39:2639-2644.
5. Schmidt J, Ebeling D, Ryschich E, et al. Pancreatic capillary blood flow in an improved model of necrotizing pancreatitis in rat. J Surg Res. 2002;106:335-341.
6. Klar E, Endlich B, Messmer K. Microcirculation of the pancreas. A quantitative study of physiology and changes in pancreatitis. Int J Microcirc Clin Exp. 1990;9:85-101.
7. Kaska M, Pospisilova B, Slizova D. Pathomorphological changes in microcirculation of pancreas during experimental acute pancreatitis. Hepatogastroenterology. 2000;47:1570-1574.
8. Foitzik T, Eibl G, Buhr HJ. Therapy for microcirculatory disorders in severe acute pancreatitis: comparison of delayed therapy with ICAM-1 antibodies and a specific endothelin A receptor antagonist. J Gastrointest Surg. 2000;4:240-246.
9. Aho HJ, Kskensalo SM, Nevalainen TJ. Experimental pancreatitis in the rat. Sodium-taurocholate-induced acute haemorrhagic pancreatitis. Scand J Gastroenterol. 1980;15:411-416.
10. ω-monomethyl-≻L- arginine, an inhibitor of the nitric oxide synthetase. Intensive Care Med. 1993;19:227-231.
11. Lomis TJ, Siffring CW, Chalasani S, et al. Nitric oxide synthase inhibitors N-monomethylarginine and aminoguanidine prevent the progressive and severe hypotension associated with a rat model of pancreatitis. Am Surg. 1995;61:7-10.
12. Pohl U, de Wit C. A unique role of NO in the control of blood flow. News Physiol Sci. 1999;14:74-80.
13. Yosumoto F, Manabe T, Ohshio G, et al. Role of pancreatic blood flow and vasoactive substances in the development of canine acute pancreatitis. J Surg Res. 1993;55:531-536.
14. Bassi D, Kollias N, Fernández-del Castillo S, et al. Impairment of pancreatic microcirculation correlates with the severity of acute experimental pancreatitis. J Am Coll Surg. 1994;179:257-263.
15. Schroder T, Millard RW, Nakajima Y, et al. Microcirculatory effects of somatostatin in acute pancreatitis. Eur Surg Res. 1988;20:82-88.
16. Foitzik T, Eibl G, Hotz B, et al. Persistent multiple organ microcirculatory disorders in severe acute pancreatitis: experimental findings and clinical implications. Dig Dis Sci. 2002;47:130-138.
17. Noji T, Nan-ya K, Mizutani M, et al. KF 24345, an adenosine uptake inhibitor, ameliorates the severity and mortality of lethal acute pancreatitis via endogenous adenosine in mice. Eur J Pharmacol. 2002;454:85-93.
18. Liu X, Nakano I, Yamaguchi H, et al. Protective effect of nitric oxide on development of acute pancreatitis in rats. Dig Dis Sci. 1995;40:2162-2169.
19. Werner J, Fernandez-del Castillo C, Rivera JA, et al. On the protective mechanisms of nitric oxide in acute pancreatitis. Gut. 1998;43:401-407.
20. Nishino T, Watanabe S, Oyama H, et al. An endothelial nitric oxide synthase inhibitor aggravates CDL-induced acute pancreatitis in rats. Pancreas. 1999;19:390-400.
21. Andrezejewska A, Jurkowska G. Nitric oxide protects the ultrastructure of pancreatic acinar cells in the course of caerulein-induced acute pancreatitis. Int J Exp Pathol. 1999;80:317-324.
22. Jaworek J, Jachimczak B, Bonior J, et al. Protective role of endogenous nitric oxide (NO) in the lipopolyssacharide-induced pancreatic damage (a new experimental model of acute pancreatitis). J Physiol Pharmacol. 2000;51:85-102.
23. Satoh A, Shimosegawa T, Kimura K, et al. Nitric oxide is overproduced by peritoneal macrophages in rat taurocholate pancreatitis: the mechanism of inducible nitric oxide synthase expression. Pancreas. 1998;17:402-411.
24. Ayub KM, Serraciono-Inglott F, Williamson RC, et al. Expression of inducible nitric oxide synthase contributes to the development of pancreatitis following pancreatic ischaemia and reperfusion. Br J Surg. 2001;88:1189-1193.
25. Liu J, Chen M, Wang X. Calcitonin gene-related peptide enhanced nitric oxide release and inducible NOS activity and mRNA expression in LPS-stimulated mouse peritoneal macrophages. Shock. 2001;16:64-69.
26. Esteban FJ, Jimenez A, Fernandez AP, et al. Neuronal nitric oxide synthase immunoreactivity in the guinea-pig liver: distribution and colocalization with neuropeptide Y and calcitonin gene-related peptide. Liver. 2001;21:374-379.
27. Warzecha Z, Dembinski A, Ceranowicz P. The influence of sensory nerves and CGRP on the pancreatic regeneration after repeated episodes of acute pancreatitis in rats. J Physiol Pharmacol. 2000;51:449-461.
28. Warzecha Z, Dembinski A, Ceranowicz P, et al. Effect of sensory nerves and CGRP on the development of caerulein-induced pancreatitis and pancreatic recovery. J Physiol Pharmacol. 2001;52:679-704.
29. Dembinski A, Warzecha Z, Ceranowicz P, et al. Stimulation of sensory nerves and CGRP attenuate pancreatic damage in ischemia/reperfusion induced pancreatitis. Med Sci Monit. 2003;9:BR418-BR425.
30. Said SI, Mutt V. Polypeptide with broad biological activity: isolation of small intestine. Science. 1970;169:1217-1218.
31. Onoue S, Endo K, Yajima T. Pituitary adenylate cyclase activating polypeptide regulates basal production of nitric oxide in PC12 cells. Life Sci. 2002;71:205-214.
32. Matsuyma H, Unno T, El-Mahmoudy AM, et al. Peptidergic and nitrergic inhibitory neurotransmissions in the hamster jejunum: regulation of vasoactive intestinal peptide release by nitric oxide. Neuroscience. 2002;110:779-788.
33. Ergun Y, Ogulener N. Evidence for interaction between nitric oxide and vasoactive intestinal polypeptide in the mouse gastric fundus. J Pharmacol Exp Ther. 2001;299:945-950.
34. Kurjak M, Fritsch R, Saur D, et al. Functional coupling between nitric oxide synthase and VIP release within enteric nerve terminals of the rat: involvement of protein kinase G and phosphodiesterase 5. J Physiol. 2001;534:827-836.
35. Chen YD, Zhou ZG, Wang Z, et al. Pituitary adenylate cyclase activating-peptide and its receptor antagonists in development of acute pancreatitis in rats. World J Gastroenterol. 2005;11:538-544.
36. Alonso RM, Rodríguez AM, García LJ, et al. Comparison between the effects of VIP and the novel peptide PACAP on the exocrine pancreatic secretion of rat. Pancreas. 1994;9:123-128.